Case Report: A Novel CACNA1S Mutation Associated With Hypokalemic Periodic Paralysis in a Chinese Family

Jie-Yuan Jin1,2, Bing-Bing Guo1,2,3, Yi Dong1

  • 1School of Life Sciences, Central South University, Changsha, China.

Frontiers in Genetics
|November 15, 2021
PubMed

Insights

Hypokalemic periodic paralysis (HypoPP), a rare genetic disorder, involves muscle weakness linked to low potassium. Researchers identified a new CACNA1S gene mutation in a Chinese patient, expanding the known causes of HypoPP.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Hypokalemic periodic paralysis (HypoPP) is a rare autosomal dominant neuromuscular disorder.
  • It is characterized by episodes of muscle weakness and low serum potassium levels.
  • Mutations in the CACNA1S gene, encoding a skeletal muscle calcium channel subunit, are found in over half of HypoPP patients.

Observation:

  • This study reports a novel frameshift mutation (c.1364delA, p.Asn455fs) in the CACNA1S gene.
  • The mutation was identified in a Chinese patient diagnosed with HypoPP.
  • Targeted sequencing was employed for mutation identification.

Findings:

  • The identified CACNA1S mutation expands the known spectrum of genetic defects causing HypoPP.
  • This specific mutation may alter calcium channel structure and function.
  • Disruption of Ca2+-mediated excitation-contraction coupling is implicated.

Implications:

  • This research enhances the understanding of HypoPP's molecular basis.
  • It contributes to the genetic landscape of Hypokalemic periodic paralysis.
  • Findings may inform future therapeutic strategies for HypoPP patients.